Moderna Inc (MRNA)
Current ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 10,325,000 | 10,799,000 | 10,599,000 | 12,122,000 | 13,431,000 | 14,297,000 | 13,563,000 | 16,350,000 | 16,071,000 | 13,425,000 | 10,969,000 | 11,703,000 | 6,298,000 | 3,577,210 | 2,796,740 | 1,249,940 | 1,128,800 | 1,094,470 | 1,097,420 | 1,140,830 |
Total current liabilities | US$ in thousands | 3,015,000 | 4,385,000 | 3,123,000 | 3,499,000 | 4,923,000 | 6,807,000 | 6,812,000 | 9,238,000 | 9,128,000 | 9,957,000 | 8,840,000 | 8,441,000 | 4,389,000 | 1,473,560 | 161,647 | 134,582 | 143,115 | 147,842 | 161,987 | 159,159 |
Current ratio | 3.42 | 2.46 | 3.39 | 3.46 | 2.73 | 2.10 | 1.99 | 1.77 | 1.76 | 1.35 | 1.24 | 1.39 | 1.43 | 2.43 | 17.30 | 9.29 | 7.89 | 7.40 | 6.77 | 7.17 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $10,325,000K ÷ $3,015,000K
= 3.42
The current ratio of Moderna Inc has exhibited fluctuations over the quarters analyzed. In Q4 2023, the current ratio stands at 3.42, indicating that the company has $3.42 in current assets for every $1 in current liabilities. This represents a strong liquidity position, suggesting that Moderna is well-equipped to cover its short-term obligations.
Comparing this with previous quarters, we observe a significant improvement from Q3 2023 (2.46) to Q4 2023, reflecting a better ability to meet short-term liabilities with current assets. Similarly, Q4 2023's current ratio is higher than in Q4 2022 (2.73), indicating enhanced liquidity management over the year.
The current trend suggests that Moderna has been efficiently managing its current assets and liabilities, resulting in improved liquidity ratios. Overall, the current ratio analysis indicates that Moderna Inc has strengthened its liquidity position, which is a positive signal for investors and stakeholders.
Peer comparison
Dec 31, 2023